((1S,2S)-2,7-Diamino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)methyl carbamate

Catalog No. :
ACCYSW526
CAS No. :
98462-75-0
Molecular Formula :
C14H16N4O5
Molecular Weight :
320.30

IUPAC Name:((1S,2S)-2,7-diamino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)methyl carbamate

((1S,2S)-2,7-Diamino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)methyl carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((1S,2S)-2,7-Diamino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)methyl carbamate
IUPAC Name((1S,2S)-2,7-diamino-1-hydroxy-6-methyl-5,8-dioxo-2,3,5,8-tetrahydro-1H-pyrrolo[1,2-a]indol-9-yl)methyl carbamate
Molecular FormulaC14H16N4O5
Molecular Weight320.30
SMILESO=C1C(C)=C(N)C(C2=C1N3C([C@@H](O)[C@@H](N)C3)=C2COC(N)=O)=O
InChI KeyXNHZZRIKMUCTHU-QTTZVWFDSA-N
SynonymMitomycin Impurity 7;Mitomycin Related Compound 2;Mitomycin Related Compound 2 (cis-1-Hydroxy-2,7-diamino Mitosene);1H-Pyrrolo[1,2-a]indole-5,8-dione, 2,7-diamino-9-[[(aminocarbonyl)oxy]methyl]-2,3-dihydro-1-hydroxy-6-methyl-, (1S,2S)-;Mitomycin Related Compound 2 Trifluoroacetate (cis-1-Hydroxy-2,7-diamino Mitosene Trifluoroacetate);Mitomycin impurity 12;Mitomycin Impurity 13
CAS No.98462-75-0

Synthetic Route by SureRoute

1. ACCYSW526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCYSW526 route product structure diagram
    ACCYSW52698462-75-0
Inquiry

2. ACCYSW526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCYSW526 route product structure diagram
    ACCYSW52698462-75-0
Inquiry

Comments (0)